-

Trish Costello
Founder & CEOPortfoliaMs. Costello is founder and CEO of Portfolia, which offers a radically different investing process designed for women and other emerging investors. She is also co-founder and CEO Emeritus of the Kauffman Fellows Program, Center for Venture Education, the global educational institute preparing the leaders of the venture capital industry, located in Palo Alto, CA. Portfolia brings investing into the 21st Century, creating entrepreneurial funds focused where women make markets, such as women's health, active aging, consumer, enterprise, food & agtech, and fashion, tech and beauty. The investing experience is smart, personalized, and educational, providing returns and market impact customized to your interests. Portfolia is building a powerful global community of sophisticated investors focusing their money and influence to build the world they want.
-

Jennifer Schneiders
President Diagnostic SolutionsHologic -

Hadine Joffee
MD, MSc, Interim Chair, Department of Psychiatry, Executive Director, Mary Horrigan Connors Center for Women's Health and Gender BiologyBrigham and Women’s Hospital & Harvard Medical School -

Shefali Goyal MS, MSc
Vice President, Head of Global RA Strategy and US Regulatory AffairsOrganon -

Monica Garcia
Assistant Director, Obstetrical and Reproductive Health Devices Team, CDRH,FDA -

Nichole YoungLin
MD, MBA, Women’s Health Clinical LeadGoogle -

Patricia Obermaier
Chief Growth Officer, Global Health and Life SciencesMicrosoft -

Asima Ahmad
Chief Medical OfficerCarrot Fertility -

Dr. Neel Shah
Chief Medical OfficerMaven Clinic -

Carolee Lee
Founder & CEOWHAM (Women's Health Access Matters)Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.
Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.
-

Elizabeth Cherot
MD, MBA, Chief Medical OfficerMarch of Dimes -

Jason Roberts
Gynecological and Surgical Devices, CDRH,FDA -

Michael Annichine
CEOMagee-Womens Research Institute -

Alice Zheng, MD, MBA, MPH
PartnerForeground Capital -

Diana Torgersen
Head of Innovation Ecosystem IntegrationOrganon -

Lisa Suennen
Managing Partner, AHA VenturesAmerican Heart Association -

Daniel Johnston
Chief, Contraception Research BranchEunice Kennedy Shriver National Institute of Child Health and Human Development -

Laura Clark-Kelly
Senior Director of Value & ReimbursementHarmony Biosciences -

Greg Singleton
Chief Artificial Intelligence OfficerUS Department of Health & Human Services -

Piraye Beim
Founder & CEOCelmatix -

Everett Handford
MBA, Regional Director, New England US Department of HealthHuman Services -

Nada Hanafi MSc, MPH
Founder & Manager, MedTech Strategy Advisors LLC; Co-FounderMedTech Color -

Susan Nicholson
MD, FIDSA, Board MemberASPIVIX -

Roslyn Holliday Moore
Deputy Director for ProgramsOffice of Behavioral Equity, US Department of Health and Human Services -

Jasmi Shah
Managing DirectorCigna Ventures -

Jaqueline Oliveira-Cella
FounderwellBe Consulting -

Lisa Marceau
CEOJoyuus -

Ariel Kramer
President & FounderKlover Communications -

Valerie Palmieri
CEOMOMENTUM Consulting -

Rachel Braun Scherl
Business Builder, Marketing Strategist, VagipreneurSPARK Solutions for Growth -

Maryon Stewart BEM
CEO and FounderFemmar Health -

Ivana Munci-Vasic
CEO & FounderVitra Labs -

Erkeda DeRouen
CEO & Principal ConsultantDigital Risk Compliance Solutions -

Brianna Brennan
Chief Innovation OfficerOntrak Health -

Claire Gill
Founder and PresidentNational Menopause Foundation -

Emilė Radyte
Co-Founder & CEOSamphire Neuroscience -

Mira Kaufman
Investment AssociateIngeborg Investments -

Rachel Robinson
Chief Operating OfficerMassMedic -

Saranya Loehrer MD, MPH
Chief Health Equity OfficerTeldoc Health -

Tamika Lane, MSN, RN, CCM
Director, Clinical Innovation and Client RelationshipsSentara Health Plans -

Andrea Olariu
CEOMedicines360 -

Cory Warner
Global Head of Customer Growth and OperationsUber Health -

Lucy Perez
PhD, Senior PrincipalMcKinsey & CompanyLucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
-

Anula Jayasuriya
Co-FounderKidron Capital -

Madison Soucie
CEO & FounderJoy LLC -

Zeynep Sabah Bagwell
Head of Personal Care42 Technology -

Tracy Warren
Senior Managing Director, Go Red for Women FundAmerican Heart Association -

Sarah Knight
Head of Healthcare Technology42 Technology -

Sabrina Martucci Johnson
President and CEODARÉ BioscienceSabrina Martucci Johnson is a life sciences executive with a record of achievement in building successful companies, launching innovative products into specialty markets, delivering returns on shareholder investments, and implementing complex directional change.
Sabrina is committed to advancing innovation in women’s health. She is the Founder and CEO of DARÉ Bioscience (NASDAQ:DARE), a clinical-stage biopharmaceutical company driven by a mission to identify, develop and bring to market a diverse portfolio of novel therapies that expand treatment options, improve outcomes and facilitate convenience for women. Prior to founding DARÉ, Sabrina was President of WomanCare Global Trading, a global provider of women’s health products, CFO/CAO of the California Institute for Biomedical Research, CFO/COO of Cypress Bioscience, Inc. (NASDAQ:CYPB), held marketing and sales positions with Advanced Tissue Sciences, and began her career in the biotechnology industry as a research scientist with Baxter Healthcare, Hyland Division, working on the recombinant factor VIII program.
Sabrina has a Master of International Management with honors from the American Graduate School of International Management (Thunderbird); a MSc. in Biochemical Engineering from the University of London, University College London; and a BSc. in Biomedical Engineering from Tulane University, magna cum laude.
Sabrina currently serves on the boards of ATAI Life Sciences, a publicly-traded clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, and Aethlon Medical, Inc., a publicly-traded company developing immunotherapeutic technologies to combat infectious disease and cancer, BIOCOM, as Vice President of Industry, the Clearity Foundation as Chair, and the YWCA of San Diego County as Past President. Additionally, Sabrina serves on the Board of Advisors of Tulane University School of Science & Engineering and on the Audit Committee of Project Concern International.
Ms. Johnson was honored by Athena, a San Diego-based business organization championing women executives and rising managers in science, technology, engineering and mathematics, with the Individual in Life Science award in 2017 and the same year received the “Moxie” for her grit and determination and positive impact in the community from the award-winning MOXIE Theatre, a Southern California theatre dedicated to producing diverse and honest images of women using the art of theatre. She was an E&Y Entrepreneur of the Year San Diego finalist in 2018 and in 2019 was recognized as an entrepreneur in the PharmaVoice 100 and honored as 2019 Director of the Year in the Emerging Board Leader category by the San Diego Corporate Directors Forum.
-

Lyn Falconio
Board MemberNAYA Biosciences -

Jennifer Lahey
Talent Optimization ConsultantPredictive Success Corporation -

Flavia Mason
Global Vice President, Women's HealthPerrigo -

Eva Temkin
Former FDA Counsel and Acting Director for PolicyFDA Office of Therapeutic Biologics -

Jenica Patterson
DirectorARPA-H -

Renee Wegryzn
Inaugural DirectorARPA-H -

Cheri Ackerman
Co-Founder & CEOConcerto Biosciences -

Elizabeth Garner
Owner & PresidentKNI Health Consultants LLC -

Gina Woods
Professor & Co-Chief, Division of Endocrinology & MetabolismUC San Diego -

Ilissa Larimore
Chief Commercial OfficerSolarea Bio -

Jyoti Gupta
President & CEOWomen's HEalth & X-Ray, GE HealthCare -

Kelsey Mayo
Co-Founder & CEOArmor Medical -

Lara Zibners
Co-FounderCalla Lily Clinical Care -

Lesley Soloman
CEO & Co-FounderVeda Trials -

Lorenzo Corsini MD
Managing DirectorBioNTech, R&D Austria -

Maike Scharp
Director, Foundation Strategy OfficeBill and Melinda Gates Foundation -

Marissa Fayer
CEO & FounderHERhealthEQ -

Ara Abrahamian
Vice President, Strategy & Corporate Development (Nutraceuticals), OtsukaManaging Director, ONCE Ventures -

Candace Tingen
Chief, Gynecologic Health and Disease Branch, NICHDNICHD -

Connie Lehman MD, PhD,
Professor of RadiologyHarvard Medical School -

Melisa Margraves
Healthcare and Life Sciences Sales LeaderHewlett Packard Enterprises -

Ramita Tandon
Chief Clinical Trials OfficerWalgreens Boots Alliance -

Sandy Milligan, MD, JD
President, Research & Development, Laboratory Operations, IT and HRAspira Women's Health -

Vivian Ota Wang PhD, FACMG, CGC
Deputy Director, Office of Research on Women's Health,NIH -

Yesmean Wahdan MD Vice President, U.S. Medical Affairs, Women’s Healthcare, Hematology, & Estab
Vice President, U.S. Medical Affairs, Women’s Healthcare, Hematology, & Established BrandsBayer -

Sarah Cross Ph.D
Vice President, Global Head Medical AffairsPremier Research -

Angela Frederickson
Principal RAQA ConsultantSparq Compliance -

Ikram Guerd
Vice President of Marketing and Managing Director USAspivix -

Laura Yecies
CEO & FounderBone Health TechnologiesLaura Yecies is the CEO of Bone Health Technologies, maker of OsteoBoost, the first effective and safe non-drug treatment for low bone density. Previously she was CEO of SyncThink a medical diagnostic company, Catch, which she sold to Apple and SugarSync which was acquired by J2Global. Earlier she led the Browser division at Netscape, was general manager of Yahoo Mail and VP of Marketing at Check Point. Ms. Yecies has led commercialization and product development programs that have resulted in the use by over 350m customers. She received her MBA from Harvard, has an MSFS from Georgetown and her AB in Government Magna Cum Laude from Dartmouth. She has been profiled in the NYTimes and multiple periodicals and is a prolific speaker and writer on health care and technology.
-

Anne Morrisey
CEO and FounderMay Health -

Dr. Dupe Burgess
CEO & FounderBloomful -

Elisha Engelen
Vice President Health TransformationAON -

Jamie White
Founder & CEOiHS Strategy LLC -

Jannine Versi
COO & Co-FounderElektra Health -

Katie Schubert
MPP, President & CEOSociety of Women's Health Research -

Kevin Eisenfrats
Co-Founder & CEOContraline -

Megan Greenfield
Affiliate Leader, McKinsey Health InstitutePartner, McKinsey & Company -

Michele Van Patten Frank
PartnerVenable LLP